Pfizer, the U.S.-based pharmaceutical giant, revealed its second-quarter financial results on Tuesday, showcasing a robust 10 ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Moreover, data on Tuesday showed that the U.S. trade deficit narrowed by more than anticipated in June, reflecting a dip in ...

Discover key insights from Arvinas, Inc.'s Q2 2025 earnings call, including CEO transition, clinical milestones, Pfizer partnership updates, and ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Amgen beat Q2 earnings and revenue expectations, raised 2025 guidance, and reported strong product sales growth across key ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Key Points Non-GAAP EPS was ($0.13), missing the consensus estimate by $0.02 (non-GAAP), due to higher pre-commercialization spending. Research and development expenses fell 48.2% compared to Q2 2024, ...

Leading the charge this morning is Smith & Nephew PLC (LSE:SN), up over 11% after the knee- and hip-replacement group ...

In a historic agreement, Union Pacific Corporation is set to merge with Norfolk Southern Corporation, establishing the first ...

Raiffeisen Bank International AG has beefed up its investment in Morgan Stanley, increasing its share count by a whopping 19.2%. This move has the banking giant holding 43,247 shares worth nearly $5 ...